+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Restasis"

From
Ophthalmic Drugs Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Ophthalmic Drugs Market - Forecasts from 2020 to 2025

  • Report
  • April 2020
  • 120 Pages
  • Global
From
The Global Ophthalmic Drugs Market - Product Thumbnail Image

The Global Ophthalmic Drugs Market

  • Report
  • October 2018
  • 104 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Restasis is a prescription eye drop used to treat chronic dry eye, a condition in which the eyes do not produce enough tears. It is part of a class of drugs known as Optical Disorders Drugs, which are used to treat a variety of eye conditions. Restasis works by increasing the production of natural tears, which helps to reduce symptoms such as burning, stinging, and irritation. It is available in both single-use vials and multi-dose bottles. Restasis is the only FDA-approved drug for the treatment of chronic dry eye, and it is the most widely prescribed drug in the Optical Disorders Drugs market. It is used by millions of people worldwide to help manage their symptoms. Restasis is also used off-label to treat other eye conditions, such as blepharitis and meibomian gland dysfunction. Some of the companies in the Restasis market include Allergan, Bausch + Lomb, and Shire. Show Less Read more